LadRx Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
17
- Stock Symbol
-
LADX
- Investments
-
1
LadRx General Information
Description
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
Contact Information
Website
www.cytrx.comCorporate Office
- 11726 San Vicente Boulevard
- Suite 650
- Los Angeles, CA 90049
- United States
Corporate Office
- 11726 San Vicente Boulevard
- Suite 650
- Los Angeles, CA 90049
- United States
LadRx Stock Performance
As of 11-Nov-2026, LadRx’s current market cap is $149.00.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $149.00 | 1.06K |
LadRx Financials Summary
As of 31-Mar-2025, LadRx has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 42 | 774 | (2,206) | 3,783 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (2,505) | (1,617) | 357 | (4,196) |
| Net Income | (2,496) | (1,590) | 400 | (4,201) |
| Total Assets | 260 | 840 | 2,308 | 2,247 |
| Total Debt | 0 | 0 | 34 | 230 |
LadRx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LadRx Comparisons
Industry
Financing
Details
LadRx Competitors (44)
One of LadRx’s 44 competitors is Innate Pharma, a Formerly VC-backed company based in Marseille, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Innate Pharma | Formerly VC-backed | Marseille, France | ||||
| Lava Therapeutics | Formerly VC-backed | Utrecht, Netherlands | ||||
| Compass Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Intercept Pharmaceuticals | Formerly VC-backed | Morristown, NJ | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX |
LadRx Patents
LadRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019309242-A1 | Imaging agents for radiolabeling exogenous and endogenous albumin | Active | 23-Jul-2018 | ||
| AU-2019309242-B2 | Imaging agents for radiolabeling exogenous and endogenous albumin | Inactive | 23-Jul-2018 | ||
| CA-3107328-A1 | Imaging agents for radiolabeling exogenous and endogenous albumin | Pending | 23-Jul-2018 | ||
| EP-3826685-A1 | Imaging agents for radiolabeling exogenous and endogenous albumin | Inactive | 23-Jul-2018 | ||
| EP-3826685-A4 | Imaging agents for radiolabeling exogenous and endogenous albumin | Inactive | 23-Jul-2018 | A61K51/0478 |
LadRx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LadRx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LadRx Acquisitions (1)
LadRx’s most recent deal was a Merger/Acquisition with INNOVIVE Pharmaceuticals for . The deal was made on 22-Sep-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| INNOVIVE Pharmaceuticals | 22-Sep-2008 | Merger/Acquisition | Drug Delivery |
LadRx ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
LadRx FAQs
-
When was LadRx founded?
LadRx was founded in 1985.
-
Where is LadRx headquartered?
LadRx is headquartered in Los Angeles, CA.
-
What is the size of LadRx?
LadRx has 17 total employees.
-
What industry is LadRx in?
LadRx’s primary industry is Biotechnology.
-
Is LadRx a private or public company?
LadRx is a Public company.
-
What is LadRx’s stock symbol?
The ticker symbol for LadRx is LADX.
-
What is the current market cap of LadRx?
The current market capitalization of LadRx is $149.00.
-
Who are LadRx’s competitors?
Innate Pharma, Lava Therapeutics, Compass Therapeutics, Intercept Pharmaceuticals, and Rein Therapeutics are some of the 44 competitors of LadRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
